Today: 21 May 2026
Browse Category

NYSE:PBR.A 7 November 2025 - 6 December 2025

Petrobras (PBR) Stock on December 6, 2025: Volatile Session, New Pre‑Salt Deals and a Leaner Dividend Future

Petrobras (PBR) Stock on December 6, 2025: Volatile Session, New Pre‑Salt Deals and a Leaner Dividend Future

Petrobras ADRs fell nearly 6% Friday to $12.10 on heavy volume after unveiling a five-year plan with lower investment and cautious dividend guidance. Analysts maintain a consensus “Moderate Buy” with a $14.90 target. No new sanctions directly target Petrobras, but traders cited political and macro concerns. Preferred ADRs closed at $11.50.
Petrobras (PBR) Stock Drops Nearly 6% as New 2026–2030 Plan Resets Dividend Hopes – Full Update for December 5, 2025

Petrobras (PBR) Stock Drops Nearly 6% as New 2026–2030 Plan Resets Dividend Hopes – Full Update for December 5, 2025

Petrobras ADRs fell nearly 6% Friday, closing at $12.13 for PBR and $11.49 for PBR.A, after unveiling a more conservative 2026–2030 business plan. Q3 2025 net income rose 23% from Q2 to R$32.7 billion, while oil and gas output hit a record 3.14 million boe/d. The stock remains mid-range for the year, with a market cap near $80 billion and a trailing P/E of about 5.8.
Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petrobras (PBR) jumps on Q3 results, R$12.16bn dividend and faster capex — Today, 7 November 2025

Petrobras shares rose after the company reported Q3 net profit of R$32.7bn and announced R$12.16bn in interim dividends for 2025. U.S.-listed PBR ADRs gained 4.7% to $12.71 by 19:25 UTC. Management said 2025 capex is ahead of plan, with about 90% of 2026 projects already contracted. Output from the Búzios field continues to ramp up, driving record exports.

Stock Market Today

  • Australia Shares Set to Rise at Open, New Zealand Markets Dip
    May 20, 2026, 7:49 PM EDT. Australian shares are expected to open higher, signaling investor confidence in the region's market outlook. In contrast, New Zealand equities are projected to decline at the open, reflecting differing economic or market responses. Market data sourced from ICE Data Services with reference information provided by FactSet, supported by multiple financial data providers. The divergence underscores the varied regional market trends in Oceania at the start of the trading session.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Go toTop